Molecular interactions of zinc(II) cyclams with polycarboxylato ligands

Four new zinc(II) cyclams of the composition {Zn(L)(tp²⁻) · H₂O}_n (1), {Zn(L)(H₂bta²⁻) · 2H₂O}_n (2), [Zn₂(L)₂(ox²⁻)] 2ClO₄ · 2DMF (3), and Zn(L)(H₂btc⁻)₂ · 2DMF (4), where L = cyclam, tp²⁻ = 1,4-benzenedicarboxylate ion, H₂bta²⁻ = 1,2,4,5-benzenetetracarboxylate ion, ox²⁻ = oxalate ion, DMF = N,N-dimethylformamide, and H₂btc⁻ = 1,3,5-benzenetricarboxylate ion, have been synthesized and structurally characterized by a combination of analytical, spectroscopic and crystallographic methods. The carboxylato ligands in the complexes 1-4 show strong coordination tendencies toward zinc(II) cyclams with hydrogen bonding interactions between the pre-organized N-H groups of the macrocycle and oxygen atoms of the carboxylato ligands. The macrocycles in 1, 2, and 4 adopt trans-III configurations with the appropriate R,R,S,S arrangement of the four chiral nitrogen centers, respectively. However, the complex 3 shows an unusual cis V conformation with the R,R,R,R nitrogen configuration. The finding of strong interactions between the carboxylato ligands and the zinc(II) ions may provide additional knowledge for the improved design of receptor-targeted zinc(II) cyclams in anti-HIV agents.     

Synthesis and characterization of the chromium(III) complexes of ethylene cross-bridged cyclam and cyclen ligands

Dichloro(4,10-dimethyl-1,4,7,10-tetraazabicyclo[5.5.2]tetradecane)chromium(III) chloride, Dichloro(4,10-dibenzyl-1,4,7,10-tetraazabicyclo[5.5.2]tetradecane) chromium(III) chloride, and Dichloro(4,11-dimethyl-1,4,8,11-tetraazabicyclo[6.6.2] hexadecane)chromium)(III) chloride have been prepared by the reaction of anhydrous chromium(III) chloride with the appropriate cross-bridged tetraazamacrocycle. Aquation of these complexes proved difficult, but Chlorohydroxo(4,11-dimethyl-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane)chromium)(III) chloride was synthesized directly from chromium(II) chloride complexation followed by exposure or the reaction to air in the presence of water. The four complexes were characterized by X-ray crystal structure determination. All contain the chromium(III) ion in a distorted octahedral geometry and the macrocycle in the cis-V configuration, as dictated by the ethylene cross-bridge. Further characterization of the hydroxo complex reveals a magnetic moment of μ_eff = 3.95 B.M. and electronic absorbtions in acetonitrile at λ_max = 583 nm (ε = 65.8 L/cm mol), 431 nm (ε = 34.8 L/cm mol) and 369 nm (ε = 17 L/cm mol).     

Crystal structure and chemical oxidation of the palladium(II) cyclam complex within the cavity of cucurbit[8]uril

Inclusion compound of a macrocyclic cavitand cucurbit[8]uril (C₄₈H₄₈N₃₂O₁₆, CB[8]) with a square-planar palladium(II) complex of a polyamine ligand cyclam, {[Pd(cyclam)]@CB[8]}Cl₂·16?H₂O (1), was synthesized and characterized by X-ray crystallography, elemental analysis, IR, and electrospray ionization (ESI) mass spectrometry. The complex [Pd(cyclam)]²⁺ undergoes chemical oxidation within the CB[8] cavity leading to the formation of the palladium(IV) inclusion compound {trans-[Pd(cyclam)Cl₂]@CB[8]}Cl₂·14H₂O (2). The Pd(II) and Pd(IV) complexes are completely encapsulated within the CB[8] cavity. The cyclam ring in 1 and 2 adopts the most stable configuration (trans-III (S,S,R,R)).     

Different coordination modes of Hdipic and dipic ligands to nickel(II) ions in a same environment (dipic = 2,6-pyridinedicarboxylate, dipicolinate)

Two new nickel(II) complexes of the composition [Ni(cyclam)(Hdipic)₂] · 2H₂O (1) and [Ni(cyclam)(H₂O)₂][Ni(dipic)₂] · 2.5H₂O (2) (cyclam = 1,4,8,11-tetraazacyclotetradecane) have been prepared and structurally characterized by a combination of analytical, spectroscopic, thermogravimetric, and crystallographic methods. The structure of 1 shows that the central nickel(II) ion is coordinated axially by two monodentate Hdipic ligands. The discrete neutral complex 1 further extends its structure by hydrogen bonding interactions to form a one-dimensional supramolecule. The structure of 2 consists of two independent nickel(II) centers. Water molecules instead of dipic ligands prefer to coordinate to the Ni1 ion forming a divalent cation [Ni(cyclam)(H₂O)₂]²⁺. Two dipic ligands coordinate to the second Ni2 ion forming a divalent anion [Ni(dipic)₂]²⁻. The divalent cations and anions are charge-balanced, resulting in a molecular salt. The divalent cations and anions are interconnected by multiple types of hydrogen bonding interactions.     

Synthesis and DNA binding ability of cyclam-amino acid conjugates

N-Substituted cyclam–amino acid conjugates have been synthesised both in solution and on the solid phase. The DNA binding affinity of these species has been studied: the nature of the amino acid strongly influences the change in melting temperature suggesting that simple cyclam–peptide conjugates could interact with DNA in a highly selective manner.     

Anions as stabilizing ligands for Ni(III)(cyclam) in aqueous solutions

Several new anions were shown to be good stabilizing ligands for , (L = 1,4,8,11-tetraazacyclotetradecane, cyclam) in aqueous solutions. , phosphonates, phosphates, including the biological relevant ATP were shown to have the highest binding constants to the tervalent nickel ion. The results suggest that the charge density of the anion at the binding site and the basicity of the anion are the main factors affecting the binding constant to the central Ni(III) cation.     

A novel tetrabranched neurotensin(8-13) cyclam derivative: synthesis, 64Cu-labeling and biological evaluation

New macrocyclic 1,4,8,11-tetraazacyclotetradecane (cyclam) derivatives with 1, 2 and 4 neurotensin(8-13) units 4, 5 and 7 have been synthesized. Compounds 4 and 5 were prepared by the reaction of non-stabilized neurotensin(8-13) and cyclamtetrapropionic acid 2 using 1-ethyl-3-(3-dimethylaminocarbonyl)carbodiimide-hydrochloride and N-hydroxysulfosuccinimide. The tetrameric compound 7 was synthesized by Michael addition of neurotensin(8-13) acrylamide 6 and cyclam 1. The copper(II) complexation behavior of 4, 5 and 7 was investigated by UV/visible spectrophotometry and shows that the metal center resides inside the N4 chromophore with additional apical interactions established with pendant arms. The novel tetrabranched NT(8-13) cyclam 7 with nanomolar neurotensin receptor 1 binding affinity was efficiently radiolabeled with ⁶⁴Cu under mild conditions. ⁶⁴Cu ⊂ 7 showed slow transchelation in the presence of a large amount of cyclam as competing ligand, while it completely remains intact in the presence of EDTA. The in vivo behavior of ⁶⁴Cu ⊂ 7 was studied in rats and mice. The metabolic stability in rodent models was high with a half-life of intact ⁶⁴Cu ⊂ 7 in plasma of 34 min in rats and 60 min in the mice, respectively. The binding affinity was high enough to demonstrate in vivo binding of ⁶⁴Cu ⊂ 7 to NTR1 overexpressing HT-29 tumor xenotransplants in nude mice. Regarding elimination, ⁶⁴Cu ⊂ 7 showed a substantial renal and reticuloendothelial accumulation. On the other hand, metabolization of the compound in vivo with a resulting metabolite—postulated to be the ⁶⁴Cu-cyclam-tetraarginine complex—also showed long retention in the circulating blood, preventing a better contrast of tumor imaging.     

In vivo effects of the controlled NO donor/scavenger ruthenium cyclam complexes on blood pressure

Ruthenium(II/III) complexes able to bind and release NO* were tested in vivo, in conscious Wistar rats instrumented for continuous blood pressure (BP) measurement and administration of in bolus injections (5 to 100 nmol/Kg i.v.) of trans-[Ru(II)Cl(NO+)(cyclam)](PF6)2 (cyclam-NO) or sodium nitroprusside (SNP). For normotensive rats, cyclam-NO produced a sustained 10% BP reduction of basal MAP during 7 +/- 0.4 to 11 +/- 0.3 min. In acute hypertensive rats, cyclam-NO produced BP reduction 3-fold larger than in normotensive rats and similar to that of SNP (maximal effect: 41 +/- 1.3 vs. 45 +/- 2.2 mmHg, respectively). However, the duration of the effect of cyclam-NO was 13 to 21-fold longer than that of SNP. The hypotensive effect of cyclam-NO was fully blocked in presence of continuous infusion of a NO* scavenger, carboxy-PTIO (6 mmol/Kg/min), or of the inhibitor of cGMP activation, methylene blue (83 nmol/Kg/min), or of the cyclam-NO precursor, trans-[RuCl(tfins)(cyclam)](tfms) (cyclam-tfms) (500 mmol/Kg/min). The long lasting BP reduction of cyclam-NO can be interpreted in terms of a slower rate of NO* release (k-NO = 2.2 x 10(-3) S(-1) at 35 degrees C) following chemical reduction (E(0') = 0.10 V vs NHE). In summary, cyclam-NO showed an hypotensive effect around 20 times longer than SNP in either normotensive or hypertensive rats, which was completely inhibited by methylene blue or carboxy-PTIO. Continuous infusion of cyclam-tfms completely blocked the hypotensive effect of cyclam-NO by scavenging the NO* released by the reduced cyclam-NO.     

Isolation of the trans-I and trans-II isomers of Cu(cyclam) via complexation with the macrocyclic host cucurbit[8]uril

The macrocyclic ligand cyclam occurs as a 70:30 mixture of its trans-I and trans-II configurations, respectively, when included as its Cu^II complex inside the cavity of the macrocyclic host compound cucurbit[8]uril. This is the first report of an unsubstituted cyclam occurring in either of these two relatively high-energy configurations in the solid state. By comparison, Ni^II(cyclam) included in CB[8] in the solid state has been shown in the literature to exist in the more stable and much more common trans-III configuration. The existence of the Cu^II(cyclam) guest in the high-energy trans-I configuration as the major isomer is postulated to be the result of the supportive nature of the CB[8] cavity, resulting from specific hydrogen bonding between the cyclam amine hydrogens and the carbonyl groups of the CB[8] host. This solid Cu^II(cyclam)@CB[8] host-guest inclusion structure also exhibits other interesting features, again distinguished from the previously reported Ni^II analog. The CB[8] hosts are only partially occupied in this solid structure, with one-third of the host cavities remaining empty. Those that are occupied show significant distortion of one of the two cavity portals, to accommodate hydrogen bonding. In addition, the Cu^II(cyclam) guest is found to reside off-centre, and to partially extend outside of the CB[8] cavity, in order to optimize hydrogen bonding interactions.     

Crystal structure and spectroscopic properties of trans-bis(nicotinato)(1,4,8,11-tetraazacyclotetradecane)chromium(III) perchlorate

The trans-[Cr(cyclam)(nic-O)₂]ClO₄ (cyclam = 1,4,8,11-tetraazacyclotetradecane; nic-O = O-coordinated nicotinate) has been prepared and structurally characterized by single-crystal X-ray diffraction at 150 K. The chromium atom is in a tetragonally compressed octahedral environment with four N atoms of the macrocyclic ligand in equatorial positions and two O-bonded nicotinates in trans axial positions. The macrocyclic cyclam adopts the centrosymmetric trans-III configuration with six- and five-membered chelate rings in chair and gauche conformation, respectively. The IR and visible spectral properties are consistent with the result of X-ray crystallography. The resolved band maxima of the electronic d-d spectrum are fitted with secular determinant for quartet state energy of d³ configuration in tetragonal field including configurational interaction. It is found that the nitrogen atoms of the cyclam ligand are a strong σ-donors and that O-bonded nicotinato group has strong σ- and π-donor characteristics toward the chromium(III) ion.